Nephroprotection of Garcinia mangostana Pericarp Extract and α-Mangostin Against Oxidative Stress in Renal Manifestation of Ulcerative Colitis in Mice
Main Article Content
Abstract
Garcinia mangostana (GM) pericarp is an herbal medicine in the Thailand National Essential Drug List. GM pericarp and its major active constituent α-mangostin (MGS) exhibit several pharmacological properties, including anti-oxidative activity. Ulcerative colitis (UC) is the consequence of prolonged oxidative stress and inflammation in the large intestine and can result in extraintestinal manifestations (EIM) in other organs. This study evaluated the impact of GM pericarp extract and MGS on oxidant-antioxidant status in the kidneys of UC-induced mice. Six-week-old ICR mice were administered orally GM pericarp extract (40, 200, and 1,000 mg kg-1 ), MGS (30 mg kg-1 ), or sulfasalazine (100 mg kg-1 ) for 7 consecutive days. UC was induced by administering dextran sulfate sodium (40 kDa; 6 g kg-1) on days 4-7. Kidneys were collected to determine the activity and expression of the catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) antioxidant enzymes, lipid peroxidation levels, and glutathione stores. UC induction suppressed expression of Cat, CuZn-Sod, Mn-Sod, and Gpx mRNAs and reduced CAT, SOD, and GPx activities in the kidneys, which was followed by an increase in lipid peroxidation. Total GSH and reduced GSH contents decreased, while oxidized GSSG content increased, reducing the GSH/GSSG ratio in the kidneys. GM and MGS improved the oxidative status of the kidneys similar to sulfasalazine by restoring the expression and activity of the antioxidant enzymes and balancing the glutathione stores. GM and MGS are promising nephroprotective antioxidant treatments and are worthy of development as alternative medicines for renal EIMs of UC.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019; 65(12):100851.
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J. Ulcerative colitis. Lancet. 2017; 389(10080):1756-1770.
Tripathi K and Feuerstein JD. New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance. Drugs Context. 2019; 8:212572.
Corica D and Romano C. Renal involvement in inflammatory bowel diseases. J Crohns Colitis. 2016; 10(2):226-235.
Jang HM, Beak HS, Kim J, Kim JY, Lee YH, Cho HY,Choe YH, Kang B, Choe BH, Choi BS, Cho MH. Renal involvement in children and adolescents with inflammatory bowel disease. Korean J Pediatr. 2018; 61(10):327-331.
Niknahad H, Heidari R, Mohammadzadeh R, Ommati MM, Khodaei F, Azarpira N, Abdoli N, Zarei M, Asadi B, Rasti M, Shirazi Yeganeh B. Sulfasalazine induces mitochondrial dysfunction and renal injury. Ren Fail. 2017; 39(1):745-753.
Chang H and Yang L. Gamma-mangostin, a micronutrient of mangosteen fruit, induces apoptosis in human colon cancer cells. Molecules. 2012; 17(7):8010-8021.
Pedraza-Chaverri J, Cárdenas-Rodríguez N, Orozco-Ibarra M, Pérez-Rojas JM. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol. 2008; 46(10):3227-3239.
EL-Kenawy AM, Hassan SMA, Osman HH. Mangosteen (Garcinia mangostana L.). In: Nabavi SM, Silva AS (Eds.). Nonvitamin and nonmineral nutritional supplements, Massachusetts, United States: Academic Press; 2019; 313-319p.
Tatiya-aphiradee N, Chatuphonprasert W, Jarukamjorn K. Ethanolic Garcinia mangostana extract and α-mangostin improve dextran sulfate sodium-induced ulcerative colitis via the suppression of inflammatory and oxidative responses in ICR mice. J Ethnopharmacol. 2021;
:113384.
Sriset Y, Chatuphonprasert W, Jarukamjorn K. Bergenin attenuates sodium selenite-induced hepatotoxicity via improvement of hepatic oxidant-antioxidant balance in HepG2 cells and ICR mice. J Biologically Act Prod Nat. 2021; 11(2):97-115.
Vuppalachi R, Juluri R, Bell LN, Ghabril M, Kamendulis L, Klaunig JE, et al. Oxidative stress in chronic liver disease: relationship between peripheral and hepatic measurements. Am J Med Sci. 2011; 324(4):314-317.
Schieber M and Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014; 24(10):R453-R462.
Phaniendra A, Jestadi DB, Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Ind J Clin Biochem. 2015; 30(1):11-26.
Yang S and Lian G. ROS and diseases: role in metabolism and energy supply. Mol Cell Biochem. 2020; 467(1):1-12.
Poljšak B and Fink R. The protective role of antioxidants in the defence against ROS/RNS-mediated environmental pollution. Oxid Med Cell Longev. 2014; 2014:671539.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-254.
Sriset Y, Chatuphonprasert W, Jarukamjorn K. Optimized models of xenobiotic-induced oxidative stress in HepG2 cells. Trop J Pharm Res. 2019; 18(5):1001:1007.
Sriset Y, Na Nakorn S, Chitsaitarn S, Dechsri K, Chatuphonprasert W, Jarukamjorn K. Bergenin exhibits a nephroprotective effect by improvement of the antioxidant system in xenobiotic-induced oxidative stress in ICR mice. Int J Pharm Phytopharm Res. 2020; 10(3):13-21.
Balmus IM, Ciobica A, Trifan A, Stanciu. The implications of oxidative stress and antioxidant therapies in inflammatory bowel disease: clinical aspects and animal models. Saudi J Gastroenterol. 2016; 22(1):3-17.
Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut. 1990; 31:786-790.
Roede JR and Fritz KS. Hepatotoxicity of reactive aldehydes. In: McQueen C (Eds.). Comprehensive Toxicology, New York, United States: Elsevier Science; 2010; 581-593p.
Rtibi K, Selmi S, Jabri M, El-Benna J, Amri M, Marzouki L, Sebai H. Protective effect of Ceratonia siliqua L. against a dextran sulfate sodium-induced alterations in liver and kidney in rat. J Med Food. 2016; 19(9):882-889.
Hasanuzzaman M, Nahar K, Anee TI, Fujita M. Glutathione in plants: biosynthesis and physiological role in environmental stress tolerance. Physiol Mol Biol Plants. 2017; 23(2):249-268.
Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allerg Organ J. 2012; 5(1):9-19.
Tham DM, Whitin JC, Cohen HJ. Increased expression of extracellular glutathione peroxidase in mice with dextran sodium sulfate-induced experimental colitis. Pediatr Res. 2002; 51(5):641-646.
Yao J, Wang J, Liu L, Li Y, Xun A, Zeng W. Anti-oxidant effects of resveratrol on mice with DSS-induced ulcerative colitis. Arch Med Res. 2010; 41(4):288-294.
Poljsak B, Šuput D, Milisav I. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxid Med Cell Longev. 2013; 2013:956792.
Rana MN, Tangpong J, Rahman MA. Xanthones protects lead-induced chronic kidney disease (CKD) via activating Nrf-2 and modulating NF-kB, MAPK pathway. Biochem Biophys Rep. 2020; 21:100718.
Elmund B and Hartrianti P. Evaluation of mangosteen (Garcinia mangostana) antioxidant activity in clinical trials and in vivo animal studies: a systematic review. J Appl Pharm Sci. 2020; 10(12):114-129.
Karim N, Jeenduang N, Tangpong J. Anti-glycemic and antihepatotoxic effects of mangosteen vinegar rind from Garcinia mangostana against HFD/STZ-induced type II diabetes in mice. Pol J Food Nutr Sci. 2018; 68(2):163-169.
Karim N, Rahman A, Chanudom L, Thongsom M, Tangpong J. Mangosteen vinegar rind from Garcinia mangostana prevents high-fat diet and streptozotocininduced type II diabetes nephropathy and apoptosis. J Food Sci. 2019; 84(5):1208-1215.